Zobrazeno 1 - 10
of 82
pro vyhledávání: '"N. A. Dobrova"'
Autor:
V. A. Aliev, Yu. A. Barsukov, Z. Z. Mamedli, V. V. Makarova, D. V. Kuzmichev, A. V. Nikolaev, I. Sh. Tataev, N. A. Dobrova, R. I. Tamrazov, Kh. E. Dzhumabaev
Publikováno v:
Тазовая хирургия и онкология, Vol 8, Iss 4, Pp 47-59 (2018)
Objective: to analyze short-term and long-term outcomes of surgical, combination, and comprehensive treatment in patients with metastatic rectal cancer.Materials and methods. We performed a retrospective analysis of prospectively collected data on th
Externí odkaz:
https://doaj.org/article/39e5302f781846829bf871aadcec4885
Publikováno v:
Современная онкология, Vol 14, Iss 4, Pp 32-35 (2012)
Externí odkaz:
https://doaj.org/article/e69118c460b347d088878dba3fa890ed
Autor:
N. V. Dobrova, A. D. Darenskaya
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 92-102 (2019)
Introduction. Colorectal cancer (CRC) holds leading positions in the cancer incidence and mortality patterns worldwide. In this regard, the study of new effective drugs and development of new treatment regimens for advanced CRC is receiving priority
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e52600eb367e5e7425ce08b3b9d5730
https://doi.org/10.21518/2079-701x-2019-19-92-102
https://doi.org/10.21518/2079-701x-2019-19-92-102
Publikováno v:
Тазовая хирургия и онкология, Vol 9, Iss 1, Pp 19-25 (2019)
This review analyzes clinical significance of Bax biomarker in colorectal cancer. We cover the most important characteristics of this protein, describe its role in the apoptosis regulation mechanisms, and asses its prognostic value. Despite the fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa88bc82f08751e2c9cab5b5aaf16606
https://doi.org/10.17650/2220-3478-2019-9-1-19-25
https://doi.org/10.17650/2220-3478-2019-9-1-19-25
Publikováno v:
Тазовая хирургия и онкология, Vol 9, Iss 1, Pp 51-59 (2019)
Objective: to evaluate the prognostic value of Bax expression in the primary colon tumor of patients with metastatic colorectal cancer (mCRC) receiving first-line treatment with a triple combination of irinotecan + oxaliplatin + long-term infusion of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11b5a4de38eb9f60fd38331d8c91dcfb
https://ok.abvpress.ru/jour/article/view/282
https://ok.abvpress.ru/jour/article/view/282
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 42-49 (2018)
A study that enrolled 30 patients with advanced colorectal cancer, who had not previously received any specific drug treatment, was conducted to develop and study a three-component regimen with oral fluoropyrimidine tegafur (Ftorafur) in outpatient p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8890618b4958a394f15bed66cda90fa
https://doi.org/10.21518/2079-701x-2018-19-42-49
https://doi.org/10.21518/2079-701x-2018-19-42-49
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 56-60 (2018)
The article considers the place of nab-paclitaxel in the treatment of metastatic breast cancer. A number of studies have shown high efficacy and acceptable toxicity in comparison with traditional taxanes. The low frequency of hypersensitivity reactio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6cc0e9bf8369c90e45d1dc4d1f5466
https://www.med-sovet.pro/jour/article/view/2747
https://www.med-sovet.pro/jour/article/view/2747
Publikováno v:
Тазовая хирургия и онкология, Vol 7, Iss 4, Pp 44-53 (2018)
Objective : to develop an effective, well-tolerated, convenient for outpatient care (without installing a subclavian catheter) three-component treatment regimen that includes ftorafur – an original oral fluoropyrimidine drug. Materials and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b41eed300ab0dd0f27c8692d7205e5dc
https://ok.abvpress.ru/jour/article/view/234
https://ok.abvpress.ru/jour/article/view/234
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 67-76 (2017)
Over the course of the past couple of decades, we have witnessed some significant improvements in the treatment of metastatic colorectal cancer: the emergence of novel targeted drugs and a differentiated approach to their administration, the extensio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e900d177e20136ba630985ac3b4c6aef
https://www.med-sovet.pro/jour/article/view/2169
https://www.med-sovet.pro/jour/article/view/2169
Publikováno v:
Медицинский совет, Vol 0, Iss 8, Pp 55-59 (2015)
Colorectal cancer is one of the most widespread cancers globally. Over the past decade, there has been a significant progress in the treatment of metastatic colorectal cancer. However, an increase in the range of effective anticancer drugs is associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::9dcaeab182b0af46c5dd1fc10560af22
https://www.med-sovet.pro/jour/article/view/229
https://www.med-sovet.pro/jour/article/view/229